HRTS Holdings Information

HRTS is an equity ETF with a total of 47 individual holdings. The top holdings are Eli Lilly and Company stock at 11.35%, Thermo Fisher Scientific at 5.60%, UnitedHealth Group at 4.98%, Novo Nordisk at 4.64%, and Merck & Co. at 4.40%.

Total Holdings

Top 10 Percentage

49.34%

Asset Class

Equity

ETF Category

Health

Assets

54.00M

PE Ratio

24.41

Breakdown by Country

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	11.35%	5,343
2	TMO	Thermo Fisher Scientific Inc.	5.60%	4,616
3	UNH	UnitedHealth Group Incorporated	4.98%	7,195
4	CPH: NOVO.B	Novo Nordisk A/S	4.64%	58,624
5	MRK	Merck & Co., Inc.	4.40%	16,233
6	JNJ	Johnson & Johnson	3.97%	7,966
7	RHHBY	Roche Holding AG	3.92%	38,978
8	RVMD	Revolution Medicines, Inc.	3.61%	9,951
9	CYTK	Cytokinetics, Incorporated	3.56%	27,649
10	GILD	Gilead Sciences, Inc.	3.31%	11,884
11	BBIO	BridgeBio Pharma, Inc.	3.10%	25,007
12	LON: AZN	AstraZeneca PLC	3.05%	9,969
13	DHR	Danaher Corporation	3.04%	7,756
14	ABT	Abbott Laboratories	2.94%	15,601
15	VRTX	Vertex Pharmaceuticals Incorporated	2.93%	3,079
16	SWX: NOVN	Novartis AG	2.64%	10,200
17	ABBV	AbbVie Inc.	2.48%	5,088
18	ISRG	Intuitive Surgical, Inc.	2.26%	3,200
19	MDT	Medtronic plc	2.23%	13,029
20	BMY	Bristol-Myers Squibb Company	2.17%	18,719
21	MCK	McKesson Corporation	1.92%	1,182
22	DXCM	DexCom, Inc.	1.55%	9,542
23	MDGL	Madrigal Pharmaceuticals, Inc.	1.48%	1,499
24	SYK	Stryker Corporation	1.41%	2,733
25	EW	Edwards Lifesciences Corporation	1.39%	8,572

Showing 25 of 47 holdings

Subscribe to see the full list

Activate Now

As of Sep 17, 2026